Greiner Bio-One GmbH | SelectScience
Greiner Bio-One GmbH products, product reviews and application articles on SelectScience.
Stay updated with breaking news from High Throughput Screening. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Greiner Bio-One GmbH products, product reviews and application articles on SelectScience.
Provides comprehensive and customizable workflows for high-throughput screening, HT-ADME and synthetic biology studies.
Proteinaceous inclusions are associated with neurodegenerative diseases and cell models are often used to determine genetic and chemical modifiers of their formation. This protocol involves the usage of automated microscopy and machine learning-based image analysis to accurately quantify the levels of protein inclusion formation in cultured cells from fluorescence microscopy images. This protocol is highly scalable and can be applied to a few images or large datasets. For complete details on the use and execution of this protocol, please refer to McAlary et al. (2022).
The Business Research Company’s Drug Discovery Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032
Dublin, Feb. 15, 2023 (GLOBE NEWSWIRE) -- The "Automated Microscopy: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's...